Priya H. Dedhia

Priya H. Dedhia

Auto-generated profile, based on publicly available information

Priya H. Dedhia

Division of Surgical Oncology, The Ohio State University and Arthur G. James Cancer Center , Columbus, OH 43210

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2017 in Science
Verified
Journal Article
Closed access
PDF file
MPMaksim V. Plikus
Maksim V. Plikus
CGChristian F. Guerrero-Juarez
Christian F. Guerrero-Juarez
MIMayumi Ito
Mayumi Ito
YLYun Li
Yun Li
PDPriya H. Dedhia
Priya H. Dedhia
GCGeorge Cotsarelis
George Cotsarelis
Hair follicles: Secret to prevent scars?: Although some animals easily regenerate limbs and heal broken flesh, mammals are generally not so gifted. Wounding can leave scars, which are characterized by a lack of hair follicles and cutaneous fat. Plikus et al. now show that hair follicles in both mice and humans can convert myofibroblasts, the predominant dermal cell in a wound, into adipocytes (see the Perspective by Chan and Longaker). The hair follicles activated the bone morphogenetic protein (BMP) signaling pathway and adipocyte transcription factors in the myofibroblast. Thus, it may be possible to reduce scar formation after wounding by adding BMP. Science , this issue p. 748 ; see also p. 693

1 June 2015 in Stem Cell Reports
Verified
Journal Article
Open access
SFStacy R. Finkbeiner
Stacy R. Finkbeiner
DHDavid Richard Hill
David Richard Hill
CAChristopher H. Altheim
Christopher H. Altheim
PDPriya H. Dedhia
Priya H. Dedhia
MTMatthew J. Taylor
Matthew J. Taylor
JSJason R. Spence
Jason R. Spence
Human intestinal organoids (HIOs) are a tissue culture model in which small intestine-like tissue is generated from pluripotent stem cells. By carrying out unsupervised hierarchical clustering of RNA-sequencing data, we demonstrate that HIOs most closely resemble human fetal intestine. We observed that genes involved in digestive tract development are enriched in both fetal intestine and HIOs compared to adult tissue, whereas genes related to digestive function and Paneth cell host defense are expressed at higher levels in adult intestine. Our study also revealed that the intestinal stem cell marker OLFM4 is expressed at very low levels in fetal intestine and in HIOs, but is robust in adult crypts. We validated our findings using in vivo transplantation to show that HIOs become more adult-like after transplantation. Our study emphasizes important maturation events that occur in the intestine during human development and demonstrates that HIOs can be used to model fetal-to-adult maturation.

1 May 2016 in Gastroenterology
Verified
Journal Article
Open access
PDF file
PDPriya H. Dedhia
Priya H. Dedhia
NBNina Bertaux-Skeirik
Nina Bertaux-Skeirik
YZYana Zavros
Yana Zavros
JSJason R. Spence
Jason R. Spence
We have greatly advanced our ability to grow a diverse range of tissue-derived and pluripotent stem cell–derived gastrointestinal (GI) tissues in vitro. These systems, broadly referred to as organoids, have allowed the field to move away from the often nonphysiological, transformed cell lines that have been used for decades in GI research. Organoids are derived from primary tissues and have the capacity for long-term growth. They contain varying levels of cellular complexity and physiological similarity to native organ systems. We review the latest discoveries from studies of tissue-derived and pluripotent stem cell–derived intestinal, gastric, esophageal, liver, and pancreatic organoids. These studies have provided important insights into GI development, tissue homeostasis, and disease and might be used to develop personalized medicines.

28 September 2016 in eLife
Verified
Journal Article
Open access
BDBriana R Dye
Briana R Dye
PDPriya H Dedhia
Priya H Dedhia
AMAlyssa J Miller
Alyssa J Miller
MNMelinda S Nagy
Melinda S Nagy
EWEric S White
Eric S White
JSJason R Spence
Jason R Spence
Human pluripotent stem cell (hPSC) derived tissues often remain developmentally immature in vitro, and become more adult-like in their structure, cellular diversity and function following transplantation into immunocompromised mice. Previously we have demonstrated that hPSC-derived human lung organoids (HLOs) resembled human fetal lung tissue in vitro (Dye et al., 2015). Here we show that HLOs required a bioartificial microporous poly(lactide-co-glycolide) (PLG) scaffold niche for successful engraftment, long-term survival, and maturation of lung epithelium in vivo. Analysis of scaffold-grown transplanted tissue showed airway-like tissue with enhanced epithelial structure and organization compared to HLOs grown in vitro. By further comparing in vitro and in vivo grown HLOs with fetal and adult human lung tissue, we found that in vivo transplanted HLOs had improved cellular differentiation of secretory lineages that is reflective of differences between fetal and adult tissue, resulting in airway-like structures that were remarkably similar to the native adult human lung.

26 August 2010 in Blood
Verified
Journal Article
Open access
PDF file
PDPriya H. Dedhia
Priya H. Dedhia
KKKaren Keeshan
Karen Keeshan
SUSacha Uljon
Sacha Uljon
LXLanwei Xu
Lanwei Xu
MVMaria E. Vega
Maria E. Vega
WPWarren S. Pear
Warren S. Pear
Trib1, Trib2, and Trib3 are mammalian homologs of Tribbles, an evolutionarily conserved Drosophila protein family that mediates protein degradation. Tribbles proteins function as adapters to recruit E3 ubiquitin ligases and enhance ubiquitylation of the target protein to promote its degradation. Increased Trib1 and Trib2 mRNA expression occurs in human myeloid leukemia and induces acute myeloid leukemia in mice, whereas Trib3 has not been associated with leukemia. Given the high degree of structural conservation among Tribbles family members, we directly compared the 3 mammalian Tribbles in hematopoietic cells by reconstituting mice with hematopoietic stem cells retrovirally expressing these proteins. All mice receiving Trib1 or Trib2 transduced hematopoietic stem cells developed acute myeloid leukemia, whereas Trib3 mice did not. Our previous data indicated that Trib2-mediated degradation of the transcription factor, CCAAT/enhancer-binding protein-alpha (C/EBPα), is important for leukemogenesis. Similar to Trib2, Trib1 induced C/EBPα degradation and inhibited its function. In contrast, Trib3 failed to inactivate or promote efficient degradation of C/EBPα. These data reveal that the 3 Tribbles homologs differ in their ability to promote degradation of C/EBPα, which account for their differential ability to induce leukemia.

2 December 2010 in Blood
Verified
Journal Article
Closed access
PDF file
KKKaren Keeshan
Karen Keeshan
WBWill Bailis
Will Bailis
PDPriya H. Dedhia
Priya H. Dedhia
MVMaria E. Vega
Maria E. Vega
OSOlga Shestova
Olga Shestova
WPWarren S. Pear
Warren S. Pear
Tribbles homolog 2 (Trib2) is a pseudokinase that induces acute myelogenous leukemia (AML) in mice and is highly expressed in a subset of human AML. Trib2 has 3 distinct regions, a proline-rich N-terminus, a serine/threonine kinase homology domain, and a C-terminal constitutive photomorphogenesis 1 (COP1)–binding domain. We performed a structure-function analysis of Trib2 using in vitro and in vivo assays. The N-terminus was not required for Trib2-induced AML. Deletion or mutation of the COP1-binding site abrogated the ability of Trib2 to degrade CCAAT/enhancer-binding protein-α (C/EBP-α), block granulocytic differentiation, and to induce AML in vivo. Furthermore, COP1 knockdown inhibited the ability of Trib2 to degrade C/EBP-α, showing that it is important for mediating Trib2 activity. We also show that the Trib2 kinase domain is essential for its function. Trib2 contains variant catalytic loop sequences, compared with conventional kinases, that we show are necessary for Trib2 activity. The kinase domain mutants bind, but cannot efficiently degrade, C/EBP-α. Together, our data demonstrate that Trib2 can bind both COP1 and C/EBP-α, leading to degradation of C/EBP-α. Identification of the functional regions of Trib2 that are essential to its oncogenic role provides the basis for developing inhibitors that will block Trib functions in cancer.